Moreover, we presented the evidence that both the frequency and epitopes of SARS-CoV-2-specific CD4+ T cells were higher than those of CD8+ T cells, which were consistent with recent findings in COVID-19 convalescents (Grifoni et al., 2020; Sekine et al., 2020). This evidence concerns the gene CD8A and COVID-19.